Rush To Live Org

We are a
non-for-profit organization dedicated to providing pre and post transplant
patient education, and to family members and friends of patients

[Stephen J. Ubl @steveubl]

We've found 3 keys to success for tackling COVID-19:
✅Standing on the shoulders of prior industry research & innovation
✅Building partnerships to get vaccines & therapeutics to patients
✅Making investments in advanced manufacturing & technology https://t.co/bI4eypLHsE

[Rush To Live Org @rushtoliveorg]

@PhRMA Great news!!!

[Stephen J. Ubl @steveubl]

Today, the first antiviral drug for the treatment of #COVID19 patients was approved by @US_FDA. Years of investment from biopharmaceutical companies, countless setbacks and endless researcher perseverance brought us to this moment. https://t.co/vkTfX34uWN

[Stephen J. Ubl @steveubl]

I am proud of my friend and former @PhRMA leader Larry Lucas who was honored by the @TheBlackCaucus last night. He has dedicated his career to improving the health and wellness of all people, particularly those who are underserved.

[Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD]

The scope of clinical trials underway for a Covid vaccine is unprecedented. Never before have so many massive trials been undertaken simultaneously in pursuit of a single goal. The oversight of safety boards is evidence of the integrity, rigor, and careful nature of this process.

[PhRMA @PhRMA]

The 340B program was created to help low-income patients access medicines at safety-net entities, but evidence shows it’s for-profit pharmacies that are benefiting instead. New analysis: https://t.co/BnO4EUBQpl

[Stephen J. Ubl @steveubl]

Proud to join my @phrma colleagues in this video series that covers how the biopharmaceutical industry is working to develop safe and effective #COVID19 vaccines https://t.co/h5SpbUAzbf

[Eli Lilly and Company @EliLillyandCo]

Just announced: Lilly will initiate a Phase 3 clinical trial to evaluate one of our medicines as a potential treatment for hospitalized #COVID19 patients. Read more: https://t.co/crwsmvSHx5

[NKF Advocacy @NKF_Advocacy]

BREAKING: @USCBO just reported that extending kidney #transplant recipient access to #Medicare's drug benefit will save $70 million over 10 years. Ask your legislators to support & pass S. 3353/H.R. 5534 today! #mykidneysmylife

[Rush To Live Org @rushtoliveorg]

Exciting to learn @HHS #CMMI demo is enabling #PartD plans to offer fixed copays for insulin beneficiaries. https://t.co/RcDUS6cFPn Retweet if you or a loved one have diabetes and would benefit from lower drug costs. #insulinsavings

[WeWorkForHealth_IL @WWFH_IL]

University of Chicago researchers are seeking recovered #COVID19 19 patients to be part of a treatment trial. https://t.co/c0bX6FGk3Z via @dailyherald

[WeWorkForHealth_IL @WWFH_IL]

Biopharma companies are working hard to defeat #COVID19. In Illinois many are taking a leading role in developing new treatments. We were happy to share these efforts with the #IL Delegation, including @SenDuckworth @DickDurbin

[WeWorkForHealth_IL @WWFH_IL]

Foreign governments should not be mandating prices in the US. The @USChamber highlights a study noting that if the US used similar drug pricing as France, Canada and the UK survival gains for certain cancer patients would be cut in half. Stop #IPI! https://t.co/DM7y5WFI4O

[Stephen J. Ubl @steveubl]

Must read from @statnews validating how Speaker Pelosi’s plan would be ‘nuclear winter’ for small biotechs. We must fix our health care system to make it work better for patients, but there are ways to do that w/o decimating R&D of new treatments & cures. https://t.co/PPxkcgpnxB

[Rush To Live Org @rushtoliveorg]

Great to present @RepSchneider with the Partnership to Fight Chronic Disease 2019 Champion of Healthy Seniors Award. #PartD is critical for transplant surviovors!

[Stephen J. Ubl @steveubl]

The Admin’s importation scheme is dangerous. No way to guarantee safety of drugs that come into the US. Rather than surrender the safety of Americans, we need solutions that would lower patient costs at the pharmacy. https://t.co/1t5xSccDUs

[Rush To Live Org @rushtoliveorg]

89% of Illinoisans say patients and their physicians, not insurers/government, should determine their course of medical treatment, according to 2019 @ALSICinnovation survey. #ALSIC #PatientsFirst https://t.co/zRTLsnoknZ

[We Work For Health @weworkforhealth]

Our Summit kicks off with a panel discussion about the changes ahead for #Medicare. #WWFH19

[WeWorkForHealth @WWFH_DE]

Ready for #WWFH19? We'll be joining @PhRMA @WWFH_CO⁩, @WWFHCT⁩,⁦ @WWFH_IL⁩, @HoosiersWFH⁩, @InnovateIowa⁩, @WWFH_MA⁩, @WWFH_NJ⁩, @WWFHNC⁩, @PAWWFH⁩,⁦ @WWFHTX⁩, ⁦@WWFHVA⁩,⁦@WWFH_WA ⁩& ⁦@WWFH_MD⁩ for 2 days in DC talking #health